Programmed Death-Ligand 1 Expression in Papillary Thyroid Cancer and Its Correlation with Clinicopathologic Factors and Recurrence
Thyroid2016Vol. 27(4), pp. 537–545
Citations Over TimeTop 10% of 2016 papers
Rong-Liang Shi, Ning Qu, Ting-xian Luo, Jun Xiang, Tian Liao, Guo-Hua Sun, Yu Wang, Yulong Wang, Caiping Huang, Qinghai Ji
Abstract
PD-L1 is important in determining aggressiveness of PTC and could predict the prognosis of patients. Therefore, inhibition of PD-L1 is suggested as a potential strategy for the treatment of advanced PTC with high expression of PD-L1.
Related Papers
- → Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013(2017)2,150 cited
- → Lessons from Mouse Models of Thyroid Cancer(2009)52 cited
- → CDK12 promotes papillary thyroid cancer progression through regulating the c-myc/β-catenin pathway(2020)20 cited
- → Modern aspects influencing the management of patients with papillary thyroid cancer(2023)3 cited
- → Evaluation of the Relationship Between Papillary Thyroid Cancer and Radiation Exposure(2024)